Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients? - Three cases of severe acute renal failure encountered in a northwestern wisconsin nephrology practice

Hemodialysis International

Volumn 13, Issue SUPLL. 1, 2009, Pages

  Onuigbo, Macaulay A C ^a,b,c  

^a MAYO CLINIC   (United States)

^b Department of Nephrology   (United States)

^c Mayo Health System Practice Based Research Network MHS PBRN   (United States)

Author keywords

Acute renal failure (ARF); Angiotensin receptor blockers (ARBs); Angiotensin converting enzyme inhibitors (ACEIs); Chronic kidney disease (CKD); RAAS blockade

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INFUSION FLUID; LISINOPRIL; LOSARTAN; TACROLIMUS; VALSARTAN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GASTROENTERITIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; METABOLIC ACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UNITED STATES;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 70349996287     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00416.x     Document Type: Article

References (42)

1. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20. The VA/NIH Acute Renal Failure Trial Network.
2. Eachempati SR, Wang JC, Hydo LJ, Shou J, Barie PS. Acute renal failure in critically surgical patients. J Trauma 2007, 63:987-993.
3. Hospitalization discharge diagnoses for kidney disease-United States, 1980-2005. MMWR Morb Mortal Wkly Rep 2008, 57:309-312. Centers for Disease Control and Prevention (CDC).
4. Ishani A, Xue JL, Himmelfarb J. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009, 20:223-228.
5. Hegarty J, Middleton RJ, Krebs M. Severe acute renal failure in adults. Q J Med 2005 Sept, 98:661-666.
6. Onuigbo M, Weir MR. Evidence-based treatment of hypertension in patients with diabetes mellitus. Diabetes Obes Metab 2003, 5:13-26.
7. Lewis EJ, Hunsicker LG, Bain RP. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456-1462. Erratum in: N Engl J Med 1993 Jan; 330:152
8. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus. Lancet 2000, 355:253-259. Erratum in: 2000; 356:860
9. Parving HH, Lehnert H, Brochner-Mortensen J. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-878.
10. Lewis EJ, Hunsicker LG, Clarke WR. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851-860.
11. Carter BL, Malone DC, Ellis SL. Antihypertensive Drug Utilization in hypertensive veterans with complex medication profiles. J Clin Hypertens (Greenwich) 2000, 2:172-180.
12. Nelson CR, Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians. Hypertension 2000, 36:600-603.
13. Onuigbo MA, Onuigbo NT. Late onset renal failure from angiotensin blockade (LORFFAB). Med Sci Monit 2005, 11:CR462-CR469.
14. Onuigbo MA, Onuigbo NT. Use of ultrahigh RAAS blockade. Kidney Int 2006, 69:194-195.
15. Onuigbo MA, Onuigbo NT. Late-onset renal failure from RAAS blockade. Kidney Int 2006, 70:1378-1379.
16. Onuigbo MA, Onuigbo NT. Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients. Int Urol Nephrol 2008, 40:233-239.
17. Onuigbo MA, Onuigbo NT. Does renin-angiotensin-aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study. Renal Fail 2008, 30:67-72.
18. Onuigbo MA, Onuigbo NT. Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors. Renal Fail 2008, 30:73-80.
19. Onuigbo MA, Onuigbo NT. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade. Q J Med 2008, 101:519-527.
20. Onuigbo MA, Onuigbo NT. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis. Renal Fail 2008, 30:363-371.
21. Onuigbo MAC. RAAS blockade, renal failure, ESRD and death among African Americans in the AASK posttrial cohort study. Arch Intern Med 2008, 168:2383-2384. Editorial Comment in Arch Intern Med 2008 Apr; 28 168:832-9
22. Onuigbo MAC. Radiographic contrast-induced nephropathy and patient mortality. Mayo Clin Proc 2008, 83:1412-1423.
23. Onuigbo MAC. Reno-prevention vs. reno-protection. Q J Med 2009, 102:155-167.
24. Onuigbo MAC, Onuigbo NTC, DeBrue Anne N. Angiotensin converting enzyme inhibitors. Angiotensin Converting Enzyme Inhibitors 2009, 1-41. In, ed., New York, Nova Biomedical Books, Nova Science Publishers
25. Parfrey PS. Inhibitors of the Renin-Angiotensin System. Ann Intern Med 2008, 148:76-77. (editorial)
26. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH. Epidemic of end-stage renal disease in people with diabetes in the United States population. Kidney Int 2005, 67:1684-1691.
27. Suissa S, Hutchinson T, Brophy JM, Kezouh A. ACE-inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int 2006, 69:913-919.
28. Louis BM, Hoch BS, Hernandez C. Protection from the nephrotoxicity of contrast dye. Renal Fail 1996, 18:639-646.
29. Toprak O, Cirit M, Bayata S, Yesil M, Aslan SL. The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg 2003, 3:98-103.
30. Cirit M, Toprak O, Yesil M. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract 2006, 104:c20-c27.
31. Komenda P, Zalunardo N, Burnett S. Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography. Clin Exp Nephrol 2007, 11:209-213.
32. Arora P, Rajagopalam S, Ranjan R. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008, 3:1266-1273.
33. Markowitz GS, Nasr SH, Klein P. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004, 35:675-684.
34. Rose M, Karlstadt RG, Walker K. Renal failure following bowel cleansing with a sodium phosphate purgative. Nephrol Dial Transplant 2005, 20:1518-1519.
35. Russmann S, Lamerato L, Marfatia A. Risk of impaired renal function after colonoscopy. Am J Gastroenterol 2007, 102:2655-2663.
36. Khurana A, McLean L, Atkinson S, Foulks CJ. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008, 168:593-597.
37. Al-Azzam SI, Al-Husein BA, Abu-Dahoud EY, Dawoud TH, Al-Momany EM. Etiologies of acute renal failure in a sample of hospitalized Jordanian patients. Renal Fail 2008, 30:373-376.
38. 2007, http://www.usrds.org/adr.htm, US Renal Data System., Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2007. Available from, (accessed date: June 18, 2008)
39. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004, 141:95-101.
40. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007, 56:161-165. Centers for Disease Control and Prevention (CDC).
41. Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int 2007, 72:208-212.
42. Mann JF, Schmieder RE, McQueen M. ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at vascular risk (the ONTARGET study). Lancet 2008, 372:547-553.